U.S. markets open in 33 minutes
  • S&P Futures

    4,119.00
    -7.50 (-0.18%)
     
  • Dow Futures

    33,656.00
    -47.00 (-0.14%)
     
  • Nasdaq Futures

    13,745.25
    -49.00 (-0.36%)
     
  • Russell 2000 Futures

    2,181.50
    -2.50 (-0.11%)
     
  • Crude Oil

    61.40
    -1.27 (-2.03%)
     
  • Gold

    1,787.00
    +8.60 (+0.48%)
     
  • Silver

    26.17
    +0.33 (+1.30%)
     
  • EUR/USD

    1.2013
    -0.0027 (-0.23%)
     
  • 10-Yr Bond

    1.5640
    +0.0020 (+0.13%)
     
  • Vix

    18.84
    +1.55 (+8.96%)
     
  • GBP/USD

    1.3905
    -0.0032 (-0.23%)
     
  • USD/JPY

    108.0520
    -0.0180 (-0.02%)
     
  • BTC-USD

    55,478.87
    -901.09 (-1.60%)
     
  • CMC Crypto 200

    1,275.50
    +41.08 (+3.33%)
     
  • FTSE 100

    6,867.87
    +8.00 (+0.12%)
     
  • Nikkei 225

    28,508.55
    -591.83 (-2.03%)
     

SUNESIS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Sunesis Pharmaceuticals, Inc. - SNSS

·1 min read

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed merger of Sunesis Pharmaceuticals, Inc. (NasdaqGS: SNSS) with Viracta Therapeutics, Inc. pursuant to which Sunesis shareholders will end up owning just 14% of the combined company, subject to adjustment. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-snss/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201229005450/en/

Contacts

Lewis S. Kahn, 855-768-1857
KSF Managing Partner
lewis.kahn@ksfcounsel.com